Brainstorm cell therapeutics expands leadership team to support clinical development and medical affairs

New york, nov. 8, 2021 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of cellular therapies for neurodegenerative diseases, today announced executive appointments as the company prepares for future growth. sidney a. spector, md, phd, was named senior vice president global strategy and medical affairs and kim thacker, md, was named senior vice president, medical affairs and clinical innovation.
BCLI Ratings Summary
BCLI Quant Ranking